Markets 24h

BTC $81,930 +1.04%

ETH $2,400 +1.32%

BNB $726 +2.10%

XRP $1.30 +2.37%

SOL $104 +2.21%

TRX $0.3308 -0.41%

HYPE $78.35 +1.62%

ZEC $1,138 +4.73%

DOGE $0.0792 +2.13%

XMR $597 +0.78%

LINK $11.97 +1.81%

LEO $9.03 +0.01%

ADA $0.2177 +0.77%

NEAR $4.95 +3.40%

XLM $0.1763 +1.23%

BCH $278 +3.59%

LTC $60.06 +3.18%

UNI $7.31 +4.39%

AVAX $9.61 +0.86%

CC $0.1043 +5.11%

Results for CHART, MSTR

3 stories, newest first

Dec 22, 2025 — Michael Saylor, MSTR

Over the past two years, the dominant narratives that investors tell about BTC company Strategy have changed over a dozen times.

As BTC crashed below the price at which Michael Saylor suggested selling a kidney, he reminded us that its price never declines in BTC terms.

The cost basis of Strategy's bitcoin purchases has steadily risen over time, yet the price of bitcoin itself is on the decline.